These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21159392)

  • 1. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
    Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
    Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease.
    Tsikas D; Thum T; Becker T; Pham VV; Chobanyan K; Mitschke A; Beckmann B; Gutzki FM; Bauersachs J; Stichtenoth DO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):229-39. PubMed ID: 17011246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
    Schnabel R; Blankenberg S; Lubos E; Lackner KJ; Rupprecht HJ; Espinola-Klein C; Jachmann N; Post F; Peetz D; Bickel C; Cambien F; Tiret L; Münzel T
    Circ Res; 2005 Sep; 97(5):e53-9. PubMed ID: 16100045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
    Işıklar OO; Barutcuoğlu B; Kabaroğlu C; Mutaf I; Özmen D; Bayındır O; Zoghi M; Uluer H
    Clin Biochem; 2012 Nov; 45(16-17):1325-30. PubMed ID: 22750146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond.
    Tsikas D
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria.
    Kanzelmeyer N; Tsikas D; Chobanyan-Jürgens K; Beckmann B; Vaske B; Illsinger S; Das AM; Lücke T
    Amino Acids; 2012 May; 42(5):1765-72. PubMed ID: 21472412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators.
    Deftereos S; Bouras G; Tsounis D; Papadimitriou C; Hatzis G; Raisakis K; Panagopoulou V; Kaoukis A; Ioannidis A; Deftereos G; Kossyvakis C; Manolis AS; Alexopoulos D; Stefanadis C; Cleman MW; Giannopoulos G
    Clin Biochem; 2014 May; 47(7-8):593-8. PubMed ID: 24525256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis.
    Ye J; Dai Y; Mao H; Zheng W; Zhang J
    Nitric Oxide; 2021 May; 109-110():50-56. PubMed ID: 33684543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.
    Post A; Bollenbach A; Bakker SJL; Tsikas D
    Amino Acids; 2021 Apr; 53(4):541-554. PubMed ID: 33651245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
    Aktoz T; Aktoz M; Tatlı E; Kaplan M; Turan FN; Barutcu A; Atakan IH; Demir M; Altun A
    Int Urol Nephrol; 2010 Dec; 42(4):873-9. PubMed ID: 20091222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
    Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
    Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J
    Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.